101 related articles for article (PubMed ID: 20472008)
1. Efficient oral delivery of paclitaxel using cyclodextrin complexes.
Park K
J Control Release; 2010 Jul; 145(1):1. PubMed ID: 20472008
[No Abstract] [Full Text] [Related]
2. Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles.
Agüeros M; Zabaleta V; Espuelas S; Campanero MA; Irache JM
J Control Release; 2010 Jul; 145(1):2-8. PubMed ID: 20347897
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of paclitaxel-conjugated β-cyclodextrin polyrotaxane and its antitumor activity.
Yu S; Zhang Y; Wang X; Zhen X; Zhang Z; Wu W; Jiang X
Angew Chem Int Ed Engl; 2013 Jul; 52(28):7272-7. PubMed ID: 23740531
[No Abstract] [Full Text] [Related]
4. Solid lipid nanoparticles of paclitaxel strengthened by hydroxypropyl-β-cyclodextrin as an oral delivery system.
Baek JS; So JW; Shin SC; Cho CW
Int J Mol Med; 2012 Oct; 30(4):953-9. PubMed ID: 22859311
[TBL] [Abstract][Full Text] [Related]
5. Preparation and the in-vivo evaluation of paclitaxel liposomes for lung targeting delivery in dogs.
Zhao L; Ye Y; Li J; Wei YM
J Pharm Pharmacol; 2011 Jan; 63(1):80-6. PubMed ID: 21155819
[TBL] [Abstract][Full Text] [Related]
6. In vitro cytotoxicity of paclitaxel/beta-cyclodextrin complexes for HIPEC.
Bouquet W; Boterberg T; Ceelen W; Pattyn P; Peeters M; Bracke M; Remon JP; Vervaet C
Int J Pharm; 2009 Feb; 367(1-2):148-54. PubMed ID: 18938234
[TBL] [Abstract][Full Text] [Related]
7. Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients.
Malingré MM; Beijnen JH; Rosing H; Koopman FJ; Jewell RC; Paul EM; Ten Bokkel Huinink WW; Schellens JH
Br J Cancer; 2001 Jan; 84(1):42-7. PubMed ID: 11139311
[TBL] [Abstract][Full Text] [Related]
8. Niosomes encapsulating paclitaxel for oral bioavailability enhancement: preparation, characterization, pharmacokinetics and biodistribution.
Sezgin-Bayindir Z; Onay-Besikci A; Vural N; Yuksel N
J Microencapsul; 2013; 30(8):796-804. PubMed ID: 23631385
[TBL] [Abstract][Full Text] [Related]
9. Cyclodextrin-poly(anhydride) nanoparticles as new vehicles for oral drug delivery.
Agüeros M; Espuelas S; Esparza I; Calleja P; Peñuelas I; Ponchel G; Irache JM
Expert Opin Drug Deliv; 2011 Jun; 8(6):721-34. PubMed ID: 21463219
[TBL] [Abstract][Full Text] [Related]
10. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel pharmacokinetics, threshold models, and dosing strategies.
Extermann M
J Clin Oncol; 2003 Jul; 21(14):2804-5; author reply 2805-6. PubMed ID: 12860962
[No Abstract] [Full Text] [Related]
12. Paclitaxel pharmacokinetics, threshold models, and dosing strategies.
Sparreboom A; Verweij J
J Clin Oncol; 2003 Jul; 21(14):2803-4; author reply 2805-6. PubMed ID: 12860961
[No Abstract] [Full Text] [Related]
13. Enhancement of water-solubility and bioactivity of paclitaxel using modified cyclodextrins.
Hamada H; Ishihara K; Masuoka N; Mikuni K; Nakajima N
J Biosci Bioeng; 2006 Oct; 102(4):369-71. PubMed ID: 17116587
[TBL] [Abstract][Full Text] [Related]
14. Altered pharmacokinetics of paclitaxel by the concomitant use of morin in rats.
Choi BC; Choi JS; Han HK
Int J Pharm; 2006 Oct; 323(1-2):81-5. PubMed ID: 16806758
[TBL] [Abstract][Full Text] [Related]
15. Flat dose (175 mg/weekly) paclitaxel: pharmacokinetics and clinical implications.
Mross K; Holländer N; Unger C; Massing U
Int J Clin Pharmacol Ther; 2005 Dec; 43(12):601-2. PubMed ID: 16372534
[No Abstract] [Full Text] [Related]
16. Paclitaxel delivery to brain tumors from hydrogels: a computational study.
Torres AJ; Zhu C; Shuler ML; Pannullo S
Biotechnol Prog; 2011; 27(5):1478-87. PubMed ID: 21786432
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel repackaged in an albumin-stabilized nanoparticle: handy or just a dandy?
Sparreboom A; Baker SD; Verweij J
J Clin Oncol; 2005 Nov; 23(31):7765-7. PubMed ID: 16258080
[No Abstract] [Full Text] [Related]
18. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
[TBL] [Abstract][Full Text] [Related]
19. A pharmacokinetic and safety study of a novel polymeric paclitaxel formulation for oral application.
Veltkamp SA; Alderden-Los C; Sharma A; Rosing H; Beijnen JH; Schellens JH
Cancer Chemother Pharmacol; 2007 Jan; 59(1):43-50. PubMed ID: 16680462
[TBL] [Abstract][Full Text] [Related]
20. Coadministration of oral cyclosporin A enables oral therapy with paclitaxel.
Meerum Terwogt JM; Malingré MM; Beijnen JH; ten Bokkel Huinink WW; Rosing H; Koopman FJ; van Tellingen O; Swart M; Schellens JH
Clin Cancer Res; 1999 Nov; 5(11):3379-84. PubMed ID: 10589748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
